Cytomegalovirus infection

3 trials 2 recruiting MedDRA PT
3 Registered trials
2 Recruiting
3 Unique sponsors
2 Unique IMPs
0 Commercial trials
Drug classes (ATC)
J Anti-infectives (ATC J) 2
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Antiviral 2 substances
Phase III: 1 Phase II: 1 Phase I (First in Human): 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

1 trial
  • Assistance Publique Hopitaux De Paris Academic
    LETERMOVIR
    2023-506216-40-00 1 country 2024 n=80
    Recruiting

Phase II

1 trial
  • Gruppo Italiano Per Il Trapianto Di Midollo Osseo Cellule Staminali Emopoietiche E Terapia Cellulare Academic
    MARIBAVIR
    2025-521074-34-00 1 country 2026 n=81
    Recruiting

Phase I (First in Human)

1 trial
  • Instituto De Investigacion Marques De Valdecilla Academic
    IMP not specified
    2024-520020-28-00 1 country n=32
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Gruppo Italiano Per Il Trapianto Di Midollo Osseo Cellule Staminali Emopoietiche E Terapia Cellulare Academic 1 Phase II 1
Assistance Publique Hopitaux De Paris Academic 1 Phase III 1
Instituto De Investigacion Marques De Valdecilla Academic 1 Phase I (First in Human) 0
New trials by year
2024
1
2026
1
← All indication landscapes